AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Acalabrutinib in Rwanda
1 product registered with RDA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Acalabrutinib Film-coated tablets, | RWANDA-FDA25/HM/0147/0009 | AstraZeneca AB | active | 4 Feb 2031 |
Acalabrutinib — RDA Registration Details
RDA (Rwanda) has 1 registered product containing Acalabrutinib, of which 1 is currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Acalabrutinib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.